Global Insulin Syringes

Insulin Syringes Comprehensive Study by Type (3/10 cc syringe, 1/2 cc syringe, 1 cc syringe, Others), Application (Hospital, Home Care, Others) Players and Region - Global Market Outlook to 2030

Insulin Syringes Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Medical industry has increased drastically and is known to be the most advanced in the way in which new treatments and methods have been developed. There has been constant technology advancement and innovation in medical field. Similarly insulin syringe also plays a vital role in it. Insulin syringe consist of three parts a needle, a barrel and plunger. It aids in delivering insulin to diabetic patients in required doses. The syringe may come in various sizes and based on the desired dosage on insulin to be administered to diabetic patients. The rising ageing population and rising number of diabetic patient globally is propelling the insulin syringe market. According to AMA Research, the market for Insulin Syringes is expected to register a CAGR of 4.9% during the forecast period to 2030. This growth is primarily driven by Aging Population and Their Vulnerability to Various diseases and Disabilities .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitK Unit
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Medical Devices sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Abbott Laboratories Inc. (United States), Becton, Dickinson, and Company (United States), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (United States), Novo Nordisk (Denmark), Sanofi (France), Eli Lilly and Company (United States), Ypsomed AG (Switzerland), Wockhardt Ltd (India), Medtronic Plc (Ireland), Gerresheimer AG (Germany), Kawamoto Corporation (Japan), Medline Industries Inc. (United States), Merit Medical Systems Inc. (United States), Nipro Medical Corporation (United States), Retractable Technologies Inc. (United States) and Schott AG (Germany), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In October 2022, Becton, Dickinson, and Company and Biocorp signed an agreement to use connected technology to track adherence to self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence and outcomes of injectable drugs, the two companies will integrate Biocorp's Injay technology. It is a solution designed to capture and transmit injection events using Near Field Communication technology to the BD UltraSafe Plus Passive Needle Guard used with pre-fillable syringes. and Source: https://www.mordorintelligence.com/industry-reports/insulin-syringes-market
In November 2023, Terumo India announced the launch of a new Insulin Syringe for patients requiring regular insulin injections. This product aims to raise the bar for patient comfort and therapy compliance.The market is seeing moderate market players, by seeing huge growth in this market the key leading vendors are highly focusing on production technologies, efficiency enhancement, and product life. This market has various growth opportunities that leading players capture via tracking the ongoing process enhancement and huge investment in market growth strategies.

Influencing Trend:
Technological Advancements Spur Growth in the Syringes, Industry Observe a Growing Trend Towards Plastic Pre Filled Syringes and Increasing Need for Further Advancements in Safety Syringes

Market Growth Drivers:
Aging Population and Their Vulnerability to Various diseases and Disabilities, Growing Incidence of Chronic Diseases and Global Pandemics Contribute to Demand and Increased Spending on Oral Care to Fuel Growth in Dental Market

Challenges:
Growing Focus Towards Development of Alternative Drug Delivery Methods

Restraints:
High Cost of Safety Syringe

Opportunities:
Expanding Injectable Market

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Insulin Syringes Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Insulin Syringes Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Insulin Syringes players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Insulin Syringes Study Sheds Light on
— The Insulin Syringes Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Insulin Syringes industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Insulin Syringes industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • 3/10 cc syringe
  • 1/2 cc syringe
  • 1 cc syringe
  • Others
By Application
  • Hospital
  • Home Care
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Aging Population and Their Vulnerability to Various diseases and Disabilities
      • 3.2.2. Growing Incidence of Chronic Diseases and Global Pandemics Contribute to Demand
      • 3.2.3. Increased Spending on Oral Care to Fuel Growth in Dental Market
    • 3.3. Market Challenges
      • 3.3.1. Growing Focus Towards Development of Alternative Drug Delivery Methods
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements Spur Growth in the Syringes
      • 3.4.2. Industry Observe a Growing Trend Towards Plastic Pre Filled Syringes
      • 3.4.3. Increasing Need for Further Advancements in Safety Syringes
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Insulin Syringes, by Type, Application and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Insulin Syringes (Value)
      • 5.2.1. Global Insulin Syringes by: Type (Value)
        • 5.2.1.1. 3/10 cc syringe
        • 5.2.1.2. 1/2 cc syringe
        • 5.2.1.3. 1 cc syringe
        • 5.2.1.4. Others
      • 5.2.2. Global Insulin Syringes by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Home Care
        • 5.2.2.3. Others
      • 5.2.3. Global Insulin Syringes Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Insulin Syringes (Volume)
      • 5.3.1. Global Insulin Syringes by: Type (Volume)
        • 5.3.1.1. 3/10 cc syringe
        • 5.3.1.2. 1/2 cc syringe
        • 5.3.1.3. 1 cc syringe
        • 5.3.1.4. Others
      • 5.3.2. Global Insulin Syringes by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Home Care
        • 5.3.2.3. Others
      • 5.3.3. Global Insulin Syringes Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Insulin Syringes (Price)
      • 5.4.1. Global Insulin Syringes by: Type (Price)
  • 6. Insulin Syringes: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton, Dickinson, and Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cardinal Health Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Novo Nordisk (Denmark)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Eli Lilly and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ypsomed AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Wockhardt Ltd (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Medtronic Plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Gerresheimer AG (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Kawamoto Corporation (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Medline Industries Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Merit Medical Systems Inc. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Nipro Medical Corporation (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Retractable Technologies Inc. (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Schott AG (Germany)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
  • 7. Global Insulin Syringes Sale, by Type, Application and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Insulin Syringes (Value)
      • 7.2.1. Global Insulin Syringes by: Type (Value)
        • 7.2.1.1. 3/10 cc syringe
        • 7.2.1.2. 1/2 cc syringe
        • 7.2.1.3. 1 cc syringe
        • 7.2.1.4. Others
      • 7.2.2. Global Insulin Syringes by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Home Care
        • 7.2.2.3. Others
      • 7.2.3. Global Insulin Syringes Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Insulin Syringes (Volume)
      • 7.3.1. Global Insulin Syringes by: Type (Volume)
        • 7.3.1.1. 3/10 cc syringe
        • 7.3.1.2. 1/2 cc syringe
        • 7.3.1.3. 1 cc syringe
        • 7.3.1.4. Others
      • 7.3.2. Global Insulin Syringes by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Home Care
        • 7.3.2.3. Others
      • 7.3.3. Global Insulin Syringes Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Insulin Syringes (Price)
      • 7.4.1. Global Insulin Syringes by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Insulin Syringes: by Type(USD Million)
  • Table 2. Insulin Syringes 3/10 cc syringe , by Region USD Million (2018-2023)
  • Table 3. Insulin Syringes 1/2 cc syringe , by Region USD Million (2018-2023)
  • Table 4. Insulin Syringes 1 cc syringe , by Region USD Million (2018-2023)
  • Table 5. Insulin Syringes Others , by Region USD Million (2018-2023)
  • Table 6. Insulin Syringes: by Application(USD Million)
  • Table 7. Insulin Syringes Hospital , by Region USD Million (2018-2023)
  • Table 8. Insulin Syringes Home Care , by Region USD Million (2018-2023)
  • Table 9. Insulin Syringes Others , by Region USD Million (2018-2023)
  • Table 10. South America Insulin Syringes, by Country USD Million (2018-2023)
  • Table 11. South America Insulin Syringes, by Type USD Million (2018-2023)
  • Table 12. South America Insulin Syringes, by Application USD Million (2018-2023)
  • Table 13. Brazil Insulin Syringes, by Type USD Million (2018-2023)
  • Table 14. Brazil Insulin Syringes, by Application USD Million (2018-2023)
  • Table 15. Argentina Insulin Syringes, by Type USD Million (2018-2023)
  • Table 16. Argentina Insulin Syringes, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Insulin Syringes, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Insulin Syringes, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Insulin Syringes, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Insulin Syringes, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Insulin Syringes, by Application USD Million (2018-2023)
  • Table 22. China Insulin Syringes, by Type USD Million (2018-2023)
  • Table 23. China Insulin Syringes, by Application USD Million (2018-2023)
  • Table 24. Japan Insulin Syringes, by Type USD Million (2018-2023)
  • Table 25. Japan Insulin Syringes, by Application USD Million (2018-2023)
  • Table 26. India Insulin Syringes, by Type USD Million (2018-2023)
  • Table 27. India Insulin Syringes, by Application USD Million (2018-2023)
  • Table 28. South Korea Insulin Syringes, by Type USD Million (2018-2023)
  • Table 29. South Korea Insulin Syringes, by Application USD Million (2018-2023)
  • Table 30. Taiwan Insulin Syringes, by Type USD Million (2018-2023)
  • Table 31. Taiwan Insulin Syringes, by Application USD Million (2018-2023)
  • Table 32. Australia Insulin Syringes, by Type USD Million (2018-2023)
  • Table 33. Australia Insulin Syringes, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Insulin Syringes, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Insulin Syringes, by Application USD Million (2018-2023)
  • Table 36. Europe Insulin Syringes, by Country USD Million (2018-2023)
  • Table 37. Europe Insulin Syringes, by Type USD Million (2018-2023)
  • Table 38. Europe Insulin Syringes, by Application USD Million (2018-2023)
  • Table 39. Germany Insulin Syringes, by Type USD Million (2018-2023)
  • Table 40. Germany Insulin Syringes, by Application USD Million (2018-2023)
  • Table 41. France Insulin Syringes, by Type USD Million (2018-2023)
  • Table 42. France Insulin Syringes, by Application USD Million (2018-2023)
  • Table 43. Italy Insulin Syringes, by Type USD Million (2018-2023)
  • Table 44. Italy Insulin Syringes, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Insulin Syringes, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Insulin Syringes, by Application USD Million (2018-2023)
  • Table 47. Netherlands Insulin Syringes, by Type USD Million (2018-2023)
  • Table 48. Netherlands Insulin Syringes, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Insulin Syringes, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Insulin Syringes, by Application USD Million (2018-2023)
  • Table 51. MEA Insulin Syringes, by Country USD Million (2018-2023)
  • Table 52. MEA Insulin Syringes, by Type USD Million (2018-2023)
  • Table 53. MEA Insulin Syringes, by Application USD Million (2018-2023)
  • Table 54. Middle East Insulin Syringes, by Type USD Million (2018-2023)
  • Table 55. Middle East Insulin Syringes, by Application USD Million (2018-2023)
  • Table 56. Africa Insulin Syringes, by Type USD Million (2018-2023)
  • Table 57. Africa Insulin Syringes, by Application USD Million (2018-2023)
  • Table 58. North America Insulin Syringes, by Country USD Million (2018-2023)
  • Table 59. North America Insulin Syringes, by Type USD Million (2018-2023)
  • Table 60. North America Insulin Syringes, by Application USD Million (2018-2023)
  • Table 61. United States Insulin Syringes, by Type USD Million (2018-2023)
  • Table 62. United States Insulin Syringes, by Application USD Million (2018-2023)
  • Table 63. Canada Insulin Syringes, by Type USD Million (2018-2023)
  • Table 64. Canada Insulin Syringes, by Application USD Million (2018-2023)
  • Table 65. Mexico Insulin Syringes, by Type USD Million (2018-2023)
  • Table 66. Mexico Insulin Syringes, by Application USD Million (2018-2023)
  • Table 67. Insulin Syringes Sales: by Type(K Unit)
  • Table 68. Insulin Syringes Sales 3/10 cc syringe , by Region K Unit (2018-2023)
  • Table 69. Insulin Syringes Sales 1/2 cc syringe , by Region K Unit (2018-2023)
  • Table 70. Insulin Syringes Sales 1 cc syringe , by Region K Unit (2018-2023)
  • Table 71. Insulin Syringes Sales Others , by Region K Unit (2018-2023)
  • Table 72. Insulin Syringes Sales: by Application(K Unit)
  • Table 73. Insulin Syringes Sales Hospital , by Region K Unit (2018-2023)
  • Table 74. Insulin Syringes Sales Home Care , by Region K Unit (2018-2023)
  • Table 75. Insulin Syringes Sales Others , by Region K Unit (2018-2023)
  • Table 76. South America Insulin Syringes Sales, by Country K Unit (2018-2023)
  • Table 77. South America Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 78. South America Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 79. Brazil Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 80. Brazil Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 81. Argentina Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 82. Argentina Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 83. Rest of South America Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 84. Rest of South America Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 85. Asia Pacific Insulin Syringes Sales, by Country K Unit (2018-2023)
  • Table 86. Asia Pacific Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 87. Asia Pacific Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 88. China Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 89. China Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 90. Japan Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 91. Japan Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 92. India Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 93. India Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 94. South Korea Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 95. South Korea Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 96. Taiwan Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 97. Taiwan Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 98. Australia Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 99. Australia Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 100. Rest of Asia-Pacific Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 101. Rest of Asia-Pacific Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 102. Europe Insulin Syringes Sales, by Country K Unit (2018-2023)
  • Table 103. Europe Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 104. Europe Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 105. Germany Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 106. Germany Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 107. France Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 108. France Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 109. Italy Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 110. Italy Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 111. United Kingdom Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 112. United Kingdom Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 113. Netherlands Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 114. Netherlands Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 115. Rest of Europe Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 116. Rest of Europe Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 117. MEA Insulin Syringes Sales, by Country K Unit (2018-2023)
  • Table 118. MEA Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 119. MEA Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 120. Middle East Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 121. Middle East Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 122. Africa Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 123. Africa Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 124. North America Insulin Syringes Sales, by Country K Unit (2018-2023)
  • Table 125. North America Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 126. North America Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 127. United States Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 128. United States Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 129. Canada Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 130. Canada Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 131. Mexico Insulin Syringes Sales, by Type K Unit (2018-2023)
  • Table 132. Mexico Insulin Syringes Sales, by Application K Unit (2018-2023)
  • Table 133. Insulin Syringes: by Type(USD/Units)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Insulin Syringes: by Type(USD Million)
  • Table 152. Insulin Syringes 3/10 cc syringe , by Region USD Million (2025-2030)
  • Table 153. Insulin Syringes 1/2 cc syringe , by Region USD Million (2025-2030)
  • Table 154. Insulin Syringes 1 cc syringe , by Region USD Million (2025-2030)
  • Table 155. Insulin Syringes Others , by Region USD Million (2025-2030)
  • Table 156. Insulin Syringes: by Application(USD Million)
  • Table 157. Insulin Syringes Hospital , by Region USD Million (2025-2030)
  • Table 158. Insulin Syringes Home Care , by Region USD Million (2025-2030)
  • Table 159. Insulin Syringes Others , by Region USD Million (2025-2030)
  • Table 160. South America Insulin Syringes, by Country USD Million (2025-2030)
  • Table 161. South America Insulin Syringes, by Type USD Million (2025-2030)
  • Table 162. South America Insulin Syringes, by Application USD Million (2025-2030)
  • Table 163. Brazil Insulin Syringes, by Type USD Million (2025-2030)
  • Table 164. Brazil Insulin Syringes, by Application USD Million (2025-2030)
  • Table 165. Argentina Insulin Syringes, by Type USD Million (2025-2030)
  • Table 166. Argentina Insulin Syringes, by Application USD Million (2025-2030)
  • Table 167. Rest of South America Insulin Syringes, by Type USD Million (2025-2030)
  • Table 168. Rest of South America Insulin Syringes, by Application USD Million (2025-2030)
  • Table 169. Asia Pacific Insulin Syringes, by Country USD Million (2025-2030)
  • Table 170. Asia Pacific Insulin Syringes, by Type USD Million (2025-2030)
  • Table 171. Asia Pacific Insulin Syringes, by Application USD Million (2025-2030)
  • Table 172. China Insulin Syringes, by Type USD Million (2025-2030)
  • Table 173. China Insulin Syringes, by Application USD Million (2025-2030)
  • Table 174. Japan Insulin Syringes, by Type USD Million (2025-2030)
  • Table 175. Japan Insulin Syringes, by Application USD Million (2025-2030)
  • Table 176. India Insulin Syringes, by Type USD Million (2025-2030)
  • Table 177. India Insulin Syringes, by Application USD Million (2025-2030)
  • Table 178. South Korea Insulin Syringes, by Type USD Million (2025-2030)
  • Table 179. South Korea Insulin Syringes, by Application USD Million (2025-2030)
  • Table 180. Taiwan Insulin Syringes, by Type USD Million (2025-2030)
  • Table 181. Taiwan Insulin Syringes, by Application USD Million (2025-2030)
  • Table 182. Australia Insulin Syringes, by Type USD Million (2025-2030)
  • Table 183. Australia Insulin Syringes, by Application USD Million (2025-2030)
  • Table 184. Rest of Asia-Pacific Insulin Syringes, by Type USD Million (2025-2030)
  • Table 185. Rest of Asia-Pacific Insulin Syringes, by Application USD Million (2025-2030)
  • Table 186. Europe Insulin Syringes, by Country USD Million (2025-2030)
  • Table 187. Europe Insulin Syringes, by Type USD Million (2025-2030)
  • Table 188. Europe Insulin Syringes, by Application USD Million (2025-2030)
  • Table 189. Germany Insulin Syringes, by Type USD Million (2025-2030)
  • Table 190. Germany Insulin Syringes, by Application USD Million (2025-2030)
  • Table 191. France Insulin Syringes, by Type USD Million (2025-2030)
  • Table 192. France Insulin Syringes, by Application USD Million (2025-2030)
  • Table 193. Italy Insulin Syringes, by Type USD Million (2025-2030)
  • Table 194. Italy Insulin Syringes, by Application USD Million (2025-2030)
  • Table 195. United Kingdom Insulin Syringes, by Type USD Million (2025-2030)
  • Table 196. United Kingdom Insulin Syringes, by Application USD Million (2025-2030)
  • Table 197. Netherlands Insulin Syringes, by Type USD Million (2025-2030)
  • Table 198. Netherlands Insulin Syringes, by Application USD Million (2025-2030)
  • Table 199. Rest of Europe Insulin Syringes, by Type USD Million (2025-2030)
  • Table 200. Rest of Europe Insulin Syringes, by Application USD Million (2025-2030)
  • Table 201. MEA Insulin Syringes, by Country USD Million (2025-2030)
  • Table 202. MEA Insulin Syringes, by Type USD Million (2025-2030)
  • Table 203. MEA Insulin Syringes, by Application USD Million (2025-2030)
  • Table 204. Middle East Insulin Syringes, by Type USD Million (2025-2030)
  • Table 205. Middle East Insulin Syringes, by Application USD Million (2025-2030)
  • Table 206. Africa Insulin Syringes, by Type USD Million (2025-2030)
  • Table 207. Africa Insulin Syringes, by Application USD Million (2025-2030)
  • Table 208. North America Insulin Syringes, by Country USD Million (2025-2030)
  • Table 209. North America Insulin Syringes, by Type USD Million (2025-2030)
  • Table 210. North America Insulin Syringes, by Application USD Million (2025-2030)
  • Table 211. United States Insulin Syringes, by Type USD Million (2025-2030)
  • Table 212. United States Insulin Syringes, by Application USD Million (2025-2030)
  • Table 213. Canada Insulin Syringes, by Type USD Million (2025-2030)
  • Table 214. Canada Insulin Syringes, by Application USD Million (2025-2030)
  • Table 215. Mexico Insulin Syringes, by Type USD Million (2025-2030)
  • Table 216. Mexico Insulin Syringes, by Application USD Million (2025-2030)
  • Table 217. Insulin Syringes Sales: by Type(K Unit)
  • Table 218. Insulin Syringes Sales 3/10 cc syringe , by Region K Unit (2025-2030)
  • Table 219. Insulin Syringes Sales 1/2 cc syringe , by Region K Unit (2025-2030)
  • Table 220. Insulin Syringes Sales 1 cc syringe , by Region K Unit (2025-2030)
  • Table 221. Insulin Syringes Sales Others , by Region K Unit (2025-2030)
  • Table 222. Insulin Syringes Sales: by Application(K Unit)
  • Table 223. Insulin Syringes Sales Hospital , by Region K Unit (2025-2030)
  • Table 224. Insulin Syringes Sales Home Care , by Region K Unit (2025-2030)
  • Table 225. Insulin Syringes Sales Others , by Region K Unit (2025-2030)
  • Table 226. South America Insulin Syringes Sales, by Country K Unit (2025-2030)
  • Table 227. South America Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 228. South America Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 229. Brazil Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 230. Brazil Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 231. Argentina Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 232. Argentina Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 233. Rest of South America Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 234. Rest of South America Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 235. Asia Pacific Insulin Syringes Sales, by Country K Unit (2025-2030)
  • Table 236. Asia Pacific Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 237. Asia Pacific Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 238. China Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 239. China Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 240. Japan Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 241. Japan Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 242. India Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 243. India Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 244. South Korea Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 245. South Korea Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 246. Taiwan Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 247. Taiwan Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 248. Australia Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 249. Australia Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 250. Rest of Asia-Pacific Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 251. Rest of Asia-Pacific Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 252. Europe Insulin Syringes Sales, by Country K Unit (2025-2030)
  • Table 253. Europe Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 254. Europe Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 255. Germany Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 256. Germany Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 257. France Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 258. France Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 259. Italy Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 260. Italy Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 261. United Kingdom Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 262. United Kingdom Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 263. Netherlands Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 264. Netherlands Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 265. Rest of Europe Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 266. Rest of Europe Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 267. MEA Insulin Syringes Sales, by Country K Unit (2025-2030)
  • Table 268. MEA Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 269. MEA Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 270. Middle East Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 271. Middle East Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 272. Africa Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 273. Africa Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 274. North America Insulin Syringes Sales, by Country K Unit (2025-2030)
  • Table 275. North America Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 276. North America Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 277. United States Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 278. United States Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 279. Canada Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 280. Canada Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 281. Mexico Insulin Syringes Sales, by Type K Unit (2025-2030)
  • Table 282. Mexico Insulin Syringes Sales, by Application K Unit (2025-2030)
  • Table 283. Insulin Syringes: by Type(USD/Units)
  • Table 284. Research Programs/Design for This Report
  • Table 285. Key Data Information from Secondary Sources
  • Table 286. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Insulin Syringes: by Type USD Million (2018-2023)
  • Figure 5. Global Insulin Syringes: by Application USD Million (2018-2023)
  • Figure 6. South America Insulin Syringes Share (%), by Country
  • Figure 7. Asia Pacific Insulin Syringes Share (%), by Country
  • Figure 8. Europe Insulin Syringes Share (%), by Country
  • Figure 9. MEA Insulin Syringes Share (%), by Country
  • Figure 10. North America Insulin Syringes Share (%), by Country
  • Figure 11. Global Insulin Syringes: by Type K Unit (2018-2023)
  • Figure 12. Global Insulin Syringes: by Application K Unit (2018-2023)
  • Figure 13. South America Insulin Syringes Share (%), by Country
  • Figure 14. Asia Pacific Insulin Syringes Share (%), by Country
  • Figure 15. Europe Insulin Syringes Share (%), by Country
  • Figure 16. MEA Insulin Syringes Share (%), by Country
  • Figure 17. North America Insulin Syringes Share (%), by Country
  • Figure 18. Global Insulin Syringes: by Type USD/Units (2018-2023)
  • Figure 19. Global Insulin Syringes share by Players 2023 (%)
  • Figure 20. Global Insulin Syringes share by Players (Top 3) 2023(%)
  • Figure 21. Global Insulin Syringes share by Players (Top 5) 2023(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Abbott Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Abbott Laboratories Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton, Dickinson, and Company (United States) Revenue: by Geography 2023
  • Figure 27. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 28. B. Braun Melsungen AG (Germany) Revenue: by Geography 2023
  • Figure 29. Cardinal Health Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cardinal Health Inc. (United States) Revenue: by Geography 2023
  • Figure 31. Novo Nordisk (Denmark) Revenue, Net Income and Gross profit
  • Figure 32. Novo Nordisk (Denmark) Revenue: by Geography 2023
  • Figure 33. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 34. Sanofi (France) Revenue: by Geography 2023
  • Figure 35. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 36. Eli Lilly and Company (United States) Revenue: by Geography 2023
  • Figure 37. Ypsomed AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 38. Ypsomed AG (Switzerland) Revenue: by Geography 2023
  • Figure 39. Wockhardt Ltd (India) Revenue, Net Income and Gross profit
  • Figure 40. Wockhardt Ltd (India) Revenue: by Geography 2023
  • Figure 41. Medtronic Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 42. Medtronic Plc (Ireland) Revenue: by Geography 2023
  • Figure 43. Gerresheimer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Gerresheimer AG (Germany) Revenue: by Geography 2023
  • Figure 45. Kawamoto Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 46. Kawamoto Corporation (Japan) Revenue: by Geography 2023
  • Figure 47. Medline Industries Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 48. Medline Industries Inc. (United States) Revenue: by Geography 2023
  • Figure 49. Merit Medical Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Merit Medical Systems Inc. (United States) Revenue: by Geography 2023
  • Figure 51. Nipro Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 52. Nipro Medical Corporation (United States) Revenue: by Geography 2023
  • Figure 53. Retractable Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 54. Retractable Technologies Inc. (United States) Revenue: by Geography 2023
  • Figure 55. Schott AG (Germany) Revenue, Net Income and Gross profit
  • Figure 56. Schott AG (Germany) Revenue: by Geography 2023
  • Figure 57. Global Insulin Syringes: by Type USD Million (2025-2030)
  • Figure 58. Global Insulin Syringes: by Application USD Million (2025-2030)
  • Figure 59. South America Insulin Syringes Share (%), by Country
  • Figure 60. Asia Pacific Insulin Syringes Share (%), by Country
  • Figure 61. Europe Insulin Syringes Share (%), by Country
  • Figure 62. MEA Insulin Syringes Share (%), by Country
  • Figure 63. North America Insulin Syringes Share (%), by Country
  • Figure 64. Global Insulin Syringes: by Type K Unit (2025-2030)
  • Figure 65. Global Insulin Syringes: by Application K Unit (2025-2030)
  • Figure 66. South America Insulin Syringes Share (%), by Country
  • Figure 67. Asia Pacific Insulin Syringes Share (%), by Country
  • Figure 68. Europe Insulin Syringes Share (%), by Country
  • Figure 69. MEA Insulin Syringes Share (%), by Country
  • Figure 70. North America Insulin Syringes Share (%), by Country
  • Figure 71. Global Insulin Syringes: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories Inc. (United States)
  • Becton, Dickinson, and Company (United States)
  • B. Braun Melsungen AG (Germany)
  • Cardinal Health Inc. (United States)
  • Novo Nordisk (Denmark)
  • Sanofi (France)
  • Eli Lilly and Company (United States)
  • Ypsomed AG (Switzerland)
  • Wockhardt Ltd (India)
  • Medtronic Plc (Ireland)
  • Gerresheimer AG (Germany)
  • Kawamoto Corporation (Japan)
  • Medline Industries Inc. (United States)
  • Merit Medical Systems Inc. (United States)
  • Nipro Medical Corporation (United States)
  • Retractable Technologies Inc. (United States)
  • Schott AG (Germany)
Additional players considered in the study are as follows:
Smiths Medical (United Kingdom) , Terumo Corp. (Japan) , Terumo Medical Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2024 226 Pages 65 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Insulin Syringes Quantitative research analysis
Global Insulin Syringes Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Insulin Syringes Market are Abbott Laboratories Inc. (United States), Becton, Dickinson, and Company (United States), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (United States), Novo Nordisk (Denmark), Sanofi (France), Eli Lilly and Company (United States), Ypsomed AG (Switzerland), Wockhardt Ltd (India), Medtronic Plc (Ireland), Gerresheimer AG (Germany), Kawamoto Corporation (Japan), Medline Industries Inc. (United States), Merit Medical Systems Inc. (United States), Nipro Medical Corporation (United States), Retractable Technologies Inc. (United States) and Schott AG (Germany) etc.
Hospital segment in Global market to hold robust market share owing to "Aging Population and Their Vulnerability to Various diseases and Disabilities ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Insulin Syringes market throughout the forecasted period.

Know More About Global Insulin Syringes Report?

Have a Query? Click Here

Other Related Reports

Ductless Fume Hoods Comprehensive Study by Type (Standard Model, With Secondary Carbon Filter, With Secondary HEPA Filter), Application (Undergraduate Teaching Labs, Industrial and Biomedical Researc...
$ 3750
Medical Tuning Fork Comprehensive Study by Type (Hartmann, Rydel-Seiffer, Others), Application (Hospitals, Clinics, Ambulatory surgical centers, Others), Material (Steel Material, Aluminum Alloy Mat...
$ 3450
Silicone Hydrogel Contact Lenses Comprehensive Study by Type (Spherical Form, Toric Form, Multifocal Form), Application (Hospital Pharmacies, Optical Shop, Online Stores, Others), Design Type (Spheri...
$ 3450
Ultrasound Imaging Comprehensive Study by Type (Grey Scale Imaging {A-Mode, B-Mode, M-Mode}, Doppler Imaging {Continuous wave Doppler, Power Doppler, Color Doppler, Duplex Doppler, Pulsed wave Dopple...
$ 3800
Eeg Electrodes Comprehensive Study by Type (Needle Electrodes, Patch Electrodes, Others), Application (Diagnostic Electrodes, Therapeutic Electrodes, Others), End Users (Hospitals, Academic & Researc...
$ 3350
Small Animal Imaging Comprehensive Study by Application (Oncology, Cardiology, Autoimmune Diseases, Neurology, Psychiatry, Others), Reagents (Optical Imaging Reagents {Bioluminescent Imaging Reagents...
$ 3750